Clinical Trials Browser

Phase 1 × plerixafor × 1 year × Clear all

NCT05088356 2026-05-12

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Phase 1 Active not recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01526096 2025-11-05

Stem Cell Transplantation for Patients With Multiple Myeloma

Phase 1 Completed

Neoplasms, Plasma Cell